- Investing Ideas
- /
- French Pharmaceuticals & Biotech High Growth Potential Companies
French Pharmaceuticals & Biotech High Growth Potential Companies
Results
14
0 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
14 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | ||
VLA | €1.92 | 5.1% | -57.7% | €312.4m | €6.83 | PS2x | E4.6% | n/a | ||
ADOC | €5.80 | -18.8% | -43.5% | €89.7m | €6.30 | PS25x | E64.0% | n/a | ||
AELIS | €2.08 | 0% | -84.4% | €28.3m | €9.10 | PS2.6x | E33.8% | n/a | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | ||
MEDCL | €16.80 | 3.1% | 153.0% | €491.1m | €22.83 | PS37.2x | E115.4% | n/a | ||
GNFT | €3.46 | -1.8% | -1.0% | €172.5m | €9.45 | PE7.7x | E41.2% | n/a | ||
DIM | €185.20 | -4.6% | -23.6% | €18.0b | €222.53 | PE112.2x | E32.0% | 0.4% | ||
ALPAT | €11.30 | -4.2% | 32.9% | €12.5m | €11.50 | n/a | E92.7% | n/a | ||
ERF | €47.96 | -0.02% | -18.8% | €9.1b | €59.46 | PE27.9x | E18.4% | 1.0% | ||
ALTHX | €0.58 | 19.4% | -48.2% | €4.5m | €6.20 | PS2x | E112.8% | n/a | ||
BOI | €26.50 | -0.9% | -34.9% | €460.1m | €33.30 | PE19.4x | E26.2% | 5.1% | ||
ALERS | €25.30 | -0.4% | 58.3% | €254.1m | €30.00 | PE38.3x | E29.0% | n/a | ||
IVA | €2.19 | -4.8% | -46.6% | €190.7m | €7.62 | PS9.9x | E16.5% | n/a |
Page 1 of 1